Sign in

CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
980542593
Phone
(877) 237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 8-K Event Shareholder vote results
  4. 8-K Event Results of operations
  5. 10-Q Report Quarterly Report
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. 4 Insider Changes in Ownership
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. S-8 Other Securities Offered to Employees in Benefit Plans
  16. 8-K Event Results of operations
  17. 10-K Report Annual Report
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G/A Stake Amended Statement of Ownership

Page 30 of 38 · 752 filings